Literature DB >> 29138153

Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.

Barbara Farrell1, Cody Black2, Wade Thompson3, Lisa McCarthy4, Carlos Rojas-Fernandez5, Heather Lochnan6, Salima Shamji7, Ross Upshur8, Manon Bouchard9, Vivian Welch10.   

Abstract

OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults.
METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline development, review, and endorsement processes. Seven clinicians (2 family physicians, 3 pharmacists, 1 nurse practitioner, and 1 endocrinologist) and a methodologist comprised the overall team; members disclosed conflicts of interest. We used a rigorous process, including the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, for guideline development. We conducted a systematic review to assess evidence for the benefits and harms of deprescribing antihyperglycemic agents. We performed a review of reviews of the harms of continued antihyperglycemic medication use, and narrative syntheses of patient preferences and resource implications. We used these syntheses and GRADE quality-of-evidence ratings to generate recommendations. The team refined guideline content and recommendation wording through consensus and synthesized clinical considerations to address common front-line clinician questions. The draft guideline was distributed to clinicians and stakeholders for review and revisions were made at each stage. A decision-support algorithm was developed to accompany the guideline. RECOMMENDATIONS: We recommend deprescribing antihyperglycemic medications known to contribute to hypoglycemia in older adults at risk or in situations where antihyperglycemic medications might be causing other adverse effects, and individualizing targets and deprescribing accordingly for those who are frail, have dementia, or have a limited life expectancy.
CONCLUSION: This guideline provides practical recommendations for making decisions about deprescribing antihyperglycemic agents. Recommendations are meant to assist with, not dictate, decision making in conjunction with patients. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29138153      PMCID: PMC5685444     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  40 in total

1.  Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people.

Authors:  R E Hubbard; M K Andrew; N Fallah; K Rockwood
Journal:  Diabet Med       Date:  2010-05       Impact factor: 4.359

Review 2.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

3.  Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.

Authors:  Daniel J Cox; Boris P Kovatchev; Linda A Gonder-Frederick; Kent H Summers; Anthony McCall; Kevin J Grimm; William L Clarke
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

4.  A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.

Authors:  Azim S Gangji; Tali Cukierman; Hertzel C Gerstein; Charles H Goldsmith; Catherine M Clase
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

5.  The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus.

Authors:  Sei J Lee; W John Boscardin; Irena Stijacic Cenzer; Elbert S Huang; Kathy Rice-Trumble; Catherine Eng
Journal:  J Am Geriatr Soc       Date:  2011-04-11       Impact factor: 5.562

Review 6.  Pitfalls in hemoglobin A1c measurement: when results may be misleading.

Authors:  Michael S Radin
Journal:  J Gen Intern Med       Date:  2013-09-04       Impact factor: 5.128

7.  Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.

Authors:  Alan J Garber; Per Clauson; Claus B Pedersen; Klaus Kølendorf
Journal:  J Am Geriatr Soc       Date:  2007-11       Impact factor: 5.562

Review 8.  Diabetes mellitus and geriatric syndromes.

Authors:  Atsushi Araki; Hideki Ito
Journal:  Geriatr Gerontol Int       Date:  2009-06       Impact factor: 2.730

9.  Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.

Authors:  Holger J Schünemann; Wojtek Wiercioch; Itziar Etxeandia; Maicon Falavigna; Nancy Santesso; Reem Mustafa; Matthew Ventresca; Romina Brignardello-Petersen; Kaja-Triin Laisaar; Sérgio Kowalski; Tejan Baldeh; Yuan Zhang; Ulla Raid; Ignacio Neumann; Susan L Norris; Judith Thornton; Robin Harbour; Shaun Treweek; Gordon Guyatt; Pablo Alonso-Coello; Marge Reinap; Jan Brozek; Andrew Oxman; Elie A Akl
Journal:  CMAJ       Date:  2013-12-16       Impact factor: 8.262

Review 10.  Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association.

Authors:  Medha N Munshi; Hermes Florez; Elbert S Huang; Rita R Kalyani; Maria Mupanomunda; Naushira Pandya; Carrie S Swift; Tracey H Taveira; Linda B Haas
Journal:  Diabetes Care       Date:  2016-02       Impact factor: 19.112

View more
  35 in total

1.  Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions.

Authors:  Ariel R Green; Patricia Lee; Emily Reeve; Jennifer L Wolff; Chi Chiung Grace Chen; Rachel Kruzan; Cynthia M Boyd
Journal:  J Am Board Fam Med       Date:  2019 May-Jun       Impact factor: 2.657

2.  Using your electronic medical record to deliver evidence-based diabetes care.

Authors:  Alexander Singer; Noah M Ivers
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

3.  Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.

Authors:  Yael Schenker; Seo Young Park; Kwonho Jeong; Jennifer Pruskowski; Dio Kavalieratos; Judith Resick; Amy Abernethy; Jean S Kutner
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

4.  The hidden curriculum and continuing professional development for family physicians.

Authors:  Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2018-05       Impact factor: 3.275

5.  Loose-control of diabetes mellitus with protamine zinc insulin in cats: 185 cases (2005-2015).

Authors:  Lisa M Restine; Gary D Norsworthy; Philip H Kass
Journal:  Can Vet J       Date:  2019-04       Impact factor: 1.008

Review 6.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

Authors:  Laura K Triantafylidis; Chelsea E Hawley; Laura P Perry; Julie M Paik
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

7.  Qualitative analysis of community pharmacists' opinions on their involvement in reducing potentially inappropriate prescribing.

Authors:  Christina Raae Hansen; Stephen Byrne; Denis O'Mahony; Patricia M Kearney; Laura J Sahm
Journal:  Eur J Clin Pharmacol       Date:  2018-10-20       Impact factor: 2.953

8.  Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults.

Authors:  Parag Goyal; Timothy S Anderson; Gwen M Bernacki; Zachary A Marcum; Ariela R Orkaby; Dae Kim; Andrew Zullo; Ashok Krishnaswami; Arlene Weissman; Michael A Steinman; Michael W Rich
Journal:  J Am Geriatr Soc       Date:  2019-09-11       Impact factor: 5.562

9.  How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment.

Authors:  Ariel R Green; Jennifer L Wolff; Diane M Echavarria; Malcolm Chapman; Annie Phung; Devon Smith; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

10.  Community pharmacists as catalysts for deprescribing: An exploratory study using quality improvement processes.

Authors:  Barbara Farrell; Chantalle Clarkin; James Conklin; Lisa Dolovich; Hannah Irving; Lisa McCarthy; Lalitha Raman-Wilms
Journal:  Can Pharm J (Ott)       Date:  2019-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.